New research into retatrutide, a dual stimulant for GLP-1 and GIP receptors, are showing promising results in treating weight gain and related 2 diabetes. Preclinical information suggest a novel mechanism contributing https://shopretatrutidepeptide.com/2026/03/12/what-is-retatrutide-peptide/